(Q48626253)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Shingo Takano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Tetsuya Yamamoto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Mika Kato Kaneko

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Eiichi Ishikawa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Yuta Tsujimoto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Masahide Matsuda

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Kei Nakai

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Ryo Yanagiya

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Shunpei Morita

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Koji Tsuboi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Akira Matsumura

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

7 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

361-373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

IDH1 and IDH2 mutations in gliomas

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Analysis of IDH1 and IDH2 mutations in Japanese glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

IDH mutation status impact on in vivo hypoxia biomarkers expression: new insights from a clinical, nuclear imaging and immunohistochemical study in 33 glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Establishment of a novel monoclonal antibody SMab-1 specific for IDH1-R132S mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Monoclonal antibody specific for IDH1 R132H mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

alpha-Internexin expression identifies 1p19q codeleted gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Alpha-internexin expression in gliomas: relationship with histological type and 1p, 19q, 10p and 10q status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Value and limitations of immunohistochemistry and gene sequencing for detection of the IDH1-R132H mutation in diffuse glioma biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

O(6)-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

MGMT activity, promoter methylation and immunohistochemistry of pretreatment and recurrent malignant gliomas: a comparative study on astrocytoma and glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

p53 abnormality and tumor invasion in patients with malignant astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Isocitrate dehydrogenase mutations in diffuse gliomas: clinical and aetiological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

IDH1 mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Molecular classification of low-grade diffuse gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Prognostic factors for survival in adult patients with cerebral low-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Genetic alterations and signaling pathways in the evolution of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

p53 in nonneoplastic central nervous system lesions: an immunohistochemical and genetic sequencing study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0837-0

Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22396072

12 December 2020

inferred from PubMed ID database lookup

Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22396072

12 December 2020

inferred from PubMed ID database lookup

Expression of mutated isocitrate dehydrogenase-1 in gliomas is associated with p53 and EGFR expression.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22396072

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S11060-012-0837-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json

release_4xjkry7tfbfyff2ftgrv72ja5a

25 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4xjkry7tfbfyff2ftgrv72ja5a

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22396072%20AND%20SRC:MED&resulttype=core&format=json